A stock that deserves closer examination: Beyond Inc (BYON)

While Beyond Inc has underperformed by -2.70%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BYON rose by 53.55%, with highs and lows ranging from $15.44 to $3.54, whereas the simple moving average jumped by 16.57% in the last 200 days.

On March 05, 2025, Needham Downgraded Beyond Inc (NYSE: BYON) to Hold. A report published by Argus on December 18, 2024, Downgraded its rating to ‘Sell’ for BYON. Needham also reiterated BYON shares as ‘Buy’, quoting a target price of $9 on the company’s shares in a report dated October 25, 2024. Maxim Group Reiterated the rating as Buy on October 25, 2024, but set its price target from $33 to $26. BofA Securities October 25, 2024d its ‘Neutral’ rating to ‘Underperform’ for BYON, as published in its report on October 25, 2024. Needham’s report from October 23, 2024 suggests a price prediction of $13 for BYON shares, giving the stock a ‘Buy’ rating. Maxim Group also rated the stock as ‘Buy’.

Analysis of Beyond Inc (BYON)

Further, the quarter-over-quarter decrease in sales is -39.38%, showing a negative trend in the upcoming months.

One of the most important indicators of Beyond Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -104.28% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.83, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

For any stock, average volume can also provide valuable insight into volatility, and BYON is recording 2.69M average volume. On a monthly basis, the volatility of the stock is set at 7.94%, whereas on a weekly basis, it is put at 7.31%, with a gain of 1.61% over the past seven days. Furthermore, long-term investors anticipate a median target price of $7.20, showing decline from the present price of $7.57, which can serve as yet another indication of whether BYON is worth investing in or should be passed over.

How Do You Analyze Beyond Inc Shares?

Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.64%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 54.17% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

Hot this week

Right Now, Here’s How You Can Trade CRISPR Therapeutics AG (CRSP) Aggressively

Currently, CRISPR Therapeutics AG's (CRSP) stock is trading at...

The VNET Group Inc ADR (VNET) Stock Is Headed for a Correction

In the current trading session, VNET Group Inc ADR's...

Choosing between riding the trend or protecting profits: Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)'s stock is trading at $10.95...

Our Attention Has Been Attracted to Glimpse Group Inc (NASDAQ:VRAR)

Glimpse Group Inc (VRAR)'s stock has witnessed a price...

Observations on the Teladoc Health Inc (NYSE:TDOC) Growth Curve

Currently, Teladoc Health Inc's (TDOC) stock is trading at...

Topics

Right Now, Here’s How You Can Trade CRISPR Therapeutics AG (CRSP) Aggressively

Currently, CRISPR Therapeutics AG's (CRSP) stock is trading at...

The VNET Group Inc ADR (VNET) Stock Is Headed for a Correction

In the current trading session, VNET Group Inc ADR's...

Choosing between riding the trend or protecting profits: Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)'s stock is trading at $10.95...

Our Attention Has Been Attracted to Glimpse Group Inc (NASDAQ:VRAR)

Glimpse Group Inc (VRAR)'s stock has witnessed a price...

Observations on the Teladoc Health Inc (NYSE:TDOC) Growth Curve

Currently, Teladoc Health Inc's (TDOC) stock is trading at...

What Are the Chances of Atyr Pharma Inc (ATYR) Stagnating? Here is the INSIGHT

Atyr Pharma Inc (ATYR)'s stock is trading at $5.59...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.